Rising health consciousness and technology innovation and R&D leading to new L-carnitine based products is driving the global L-carnitine market
Covid-19 Impact & Market Status
Covid-19 caused long-term effect on the global L-carnitine market due to lockdown restrictions. This led to supply chain disruptions, shortage of raw materials, and reduced market demand.
The key objective of creating this latest report on global carnitine market is to identify the latest trends influencing the market of carnitine industry. The report analyses the current economic situation of the carnitine market from regional and global point of view and development trends in the international carnitine market. the report conducts quantitative analysis of the global carnitine market, determines the size and structure of the global carnitine market, and evaluates how is the demand for the carnitine market in key countries. The report analyses how big is the market demand for carnitine in European, American, African, Asian and other key regions. The report does international and national economic comparison of the carnitine industry. The report determines the forecast development of the carnitine industry from 2022 to 2029. The report determines the market size and growth rate forecasts until 2029 and determines the demand in millions of US dollar.
L-Carnitine Segment Experienced More Demand
The global L-carnitine market is classified into L-carnitine, acetyl-L-carnitine, propionyl-L-carnitine on the basis of L-carnitine form. Among these, the L-carnitine segment experienced more demand in the market. The factors such as antioxidating properties, improved exercise performance, enhanced sense of well-being, and natural compound to aid weight loss are driving its demand in the market.
Chemical Extraction Process Is More Popular
The global L-carnitine market is classified into biochemical production and chemical on the basis of extraction process. Among these, the chemical extraction process is more popular in production plants.
Post Exercise Recovery Segment Experienced More Demand for L-carnitine
The global L-carnitine market is classified into post-exercise recovery, weight management, AIDS-related dementia complex, athletic performance, migraine prophylaxis, cardiovascular disease, diabetes mellitus, dyslipidemia, cachexia, other on the basis of application. Among these, L-carnitine is in more consumed by athletes for post-exercise recovery.
North America Is The Dominant Region
During the projected period, the North American region in the L-carnosine market is expected to increase at a CAGR of roughly 6.0 percent. A large incidence of Autistic Spectrum Disorders (ASD) and chronic conditions such as diabetes and cardiovascular disease (CVD) are contributing to market expansion. Furthermore, the country's high level of knowledge about the use of dietary supplements contributes to the market's regional expansion. According to the Centers for
Disease Control and Prevention (CDC), roughly 1 in 6 (17%) children aged 3 to 17 years were diagnosed with a developmental impairment in the United States between 2009 and 2017. Blindness, autism, cerebral palsy, attention deficit hyperactivity disorder, and other conditions were included. This might increase the demand for nutritional supplements in children being treated for ASD. L-Carnosine is the first dietary supplement that has been shown to help with cognitive and behavioural problems. DHA (docosahexaenoic acid) is a fatty acid that promotes learning and memory. Dr. Chez's study suggests that L-Carnosine can help with auditory processing, receptive language, socialising, and awareness of one's environment.
Owing to benefits such as, antioxidant, improved exercise performance, enhanced sense of well-being, and natural aid weight loss, the L-carnitine is experiencing rapid adoption as opposed to other alternatives thus fostering remarkable progress in global L-carnitine market.
The factors such as, enhanced heart health awareness campaigns, rising population diagnosed with cardiovascular and other diseases such as diabetes, etc are driving the global L-carnitine market.
The global L-Carnitine market is anticipated to reach $225 million by 2029, with a 4.56 percent compound annual growth rate (CAGR) throughout the forecast period, 2022-2029.
L-carnosine protects against protein glycation, which can cause kidney and nerve damage in patients with diabetes. L-carnosine is required for regular physiological functions such as heart, muscle, brain, kidney, and other organ growth and functioning.
L-carnitine is a naturally occurring amino acid structure in the body. It is naturally found in other sources also such as meat, fish, poultry, milk, and plant sources. L-carnitine retainn moisture due to its hygroscopic nature. L-carnitine is used as a supplement by premature new-borns, vegetarians, and dieters. L-carnitine may also have a role in cardiovascular health, sports nutrition, weight management, and energy maintenance during pregnancy. L-carnitine has been proven to aid in the recovery of the elderly following exercise. It also assists in the decrease of fatigue and improvement of mental function.
It also lowers the risk of skeletal deterioration, which is common among the elderly. The supplement promotes healthy ageing by preserving lean muscle mass, reducing muscle degeneration, and promoting lean muscle mass maintenance. Obesity-related diseases such as chronic weariness, diabetes, and heart attack are can also be treated with l-carnitine consumption. Thus the demand for L-carnitine is increased furthering the development of global L-carnitine market. However, in addition to these good traits, there are also concerns that might impede market expansion.
These are just a few of the elements that might provide producers with extra chances in the next assessment period. Manufacturing-related technical advancements are likely to be a major driver of global L-carnitine market growth. The intricacy of the manufacturing process, as well as false marketing that promotes exaggerated product benefits, are expected to stymie the market. The sector is also expected to face regulatory constraints due to the significant volume of trash and wastewater created by industrial activities.
Furthermore, enhanced heart health awareness campaigns, rising population diagnosed with cardiovascular diseases, rising healthcare awareness, new product launches is anticipated to a growth opportunity for the global L-carnitine market.
The major players in global L-carnitine market are HuBei YuanCheng SaiChuang Technology, HuangGang HuaYang Pharmaceutical, ChengDa Pharmaceuticals, Kaiyuan Hengtai Chemical, Ceva Sante Animale, Tokyo Chemical Industry, Cayman Chemical Company, Northeast Pharmaceutical, Lonza, and Merck among others.
Latest Innovation in the Golf L-carnitine Market: A Snapshot
- Several studies have shown that acetyl L-Carnitine (LC) has a beneficial effect on T lymphocyte growth and maturation, which is implicated in the immunological response to viral pathogens. It also helps to limit ROS formation and remodulate the cytokine network that is characteristic of the systemic inflammatory syndrome. Carnitine and its derivative acetyl-carnitine give protection against severe COVID-19, according to researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK. A 40-percent decrease in the probability of disease development is linked to doubling carnitine or acetyl-carnitine intake.
L-Carnitine Market Scope
|Forecast Unit||Value (USD)|
|Revenue forecast in 2028||$225 million|
|Growth Rate||CAGR of 4.56% during 2021-2028|
|Segment Covered||Extraction Process, Application, Form, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and South Africa|
|Key Players Profiled||HuBei YuanCheng SaiChuang Technology, HuangGang HuaYang Pharmaceutical, ChengDa Pharmaceuticals, Kaiyuan Hengtai Chemical, Ceva Sante Animale, Tokyo Chemical Industry, Cayman Chemical Company.|
Key Segments of the L-Carnosine Market
Extraction Process Overview, 2019-2029 (USD Million)
Application Overview, 2019-2029 (USD Million)
- Aids-Related Dementia Complex
- Athletic Performance
- Migraine Prophylaxis
- Cardiovascular Disease
- Diabetes Mellitus
Form Overview, 2019-2029 (USD Million)
Regional Overview, 2019-2029 (USD Million)
- Rest of Europe
- Rest of Asia Pacific
- Rest of South America
Middle East and South Africa